Soluble receptor for advanced glycation end-products and progression of airway disease

[11] Yerkovich ST(2006)High-mobility group box 1 (HMGB1) protein: friend and foe Cytokine Growth Factor Rev 17 189-569

[12] Towers MA(2010)Expression of high-mobility group box 1 and of receptor for advanced glycation end products in chronic obstructive pulmonary disease Am J Respir Crit Care Med 181 917-261

[13] Carroll ML(2011)High mobility group protein B1 (HMGB1) in Asthma: comparison of patients with chronic obstructive pulmonary disease and healthy controls Mol Med 17 807-46

[14] Thomas R(2013)Plasma sRAGE and N-(carboxymethyl) lysine in patients with CHF and/or COPD Eur J Clin Invest 43 562-284

[15] Upham JW(2014)High expression of high-mobility group box 1 in the blood and lungs is associated with the development of chronic obstructive pulmonary disease in smokers Respirology 19 253-20

[16] Sukkar MB(2010)Early detection of COPD combined with individualized counselling for smoking cessation: a two-year prospective study Scand J Prim Health Care 28 41-365

[17] Wood LG(2011)Elevation of surfactant protein A in plasma and sputum in cigarette smokers Eur Respir J 38 277-1184

[18] Tooze M(1982)Spirometric studies in non-smoking, healthy adults Scand J Clin Lab Invest Suppl 159 5-468

[19] Simpson JL(2013)Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease, GOLD executive summary Am J Respir Crit Care Med 187 347-390

[20] McDonald VM(2007)Gender and chronic obstructive pulmonary disease: why it matters Am J Respir Crit Care Med 176 1179-488

[11] Yerkovich ST(2006)High-mobility group box 1 (HMGB1) protein: friend and foe Cytokine Growth Factor Rev 17 189-569

[12] Towers MA(2010)Expression of high-mobility group box 1 and of receptor for advanced glycation end products in chronic obstructive pulmonary disease Am J Respir Crit Care Med 181 917-261

[13] Carroll ML(2011)High mobility group protein B1 (HMGB1) in Asthma: comparison of patients with chronic obstructive pulmonary disease and healthy controls Mol Med 17 807-46

[14] Thomas R(2013)Plasma sRAGE and N-(carboxymethyl) lysine in patients with CHF and/or COPD Eur J Clin Invest 43 562-284

[15] Upham JW(2014)High expression of high-mobility group box 1 in the blood and lungs is associated with the development of chronic obstructive pulmonary disease in smokers Respirology 19 253-20

[16] Sukkar MB(2010)Early detection of COPD combined with individualized counselling for smoking cessation: a two-year prospective study Scand J Prim Health Care 28 41-365

[17] Wood LG(2011)Elevation of surfactant protein A in plasma and sputum in cigarette smokers Eur Respir J 38 277-1184

[18] Tooze M(1982)Spirometric studies in non-smoking, healthy adults Scand J Clin Lab Invest Suppl 159 5-468

[19] Simpson JL(2013)Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease, GOLD executive summary Am J Respir Crit Care Med 187 347-390

[20] McDonald VM(2007)Gender and chronic obstructive pulmonary disease: why it matters Am J Respir Crit Care Med 176 1179-488